Stock Analysis

The pivot toward antimony is the defining development. Felix Gold's Treasure Creek project in Alaska, historically pursued for gold in the renowned Tintina gold province, hosts antimony mineralisation that the company is now advancing as a near-term production opportunity toSupplydomestic United StatesDemandfor defence, energy …

The operating story has been one of rapid, defence-led growth. Elsight reported that full-year 2025 revenue rose roughly eleven-fold to around US$23 million and that the company reached profitability, a remarkable turn for aBusinessthat was sub-scale only a year earlier. That momentum accelerated into …

Mesoblast spent the middle of last week rallying hard on clinical news, so the pullback of almost 5% on 21 August looks less like a fresh blow and more like the market handing some of those gains back. The cell-therapy company jumped on 17 …

The move fits a pattern that has built since the company released a definitive feasibility study on Gum Creek and continued to report broad, high-grade drilling intercepts from prospects including Kingfisher, Hawk and Swan.

Clarity is a clinical-stage developer of targeted radiopharmaceuticals, using its copper-based "Targeted Copper Theranostic" platform to both image and treat cancer. Its lead programs are SAR-bisPSMA, aimed at prostate cancer in both diagnostic and therapeutic settings, and SAR-Bombesin, being explored across several tumour types. …

Nuix sells investigative analytics and intelligence software used by regulators, law-enforcement agencies, corporations and law firms to process and interrogate very large volumes of unstructured data with forensic precision. The company's strategic pivot in recent years has centred on Nuix Neo, a newer platform …

The renamed company has pivoted from pure exploration towards near-term production, centred on the White Dam gold operation in South Australia's Curnamona/Broken Hill mineral province. White Dam is a past producer that yielded roughly 180,000 ounces between 2010 and 2018 at cash costs reported …